Themis Medicare (NSE:THEMISMED) FFO


NSE:THEMISMED Themis Medicare Ltd NSE:THEMISMED
78 GF Score
Price ₹118.59
GF Value ₹149.24
Valuation Modestly Undervalued
! 7 Warning Signs
View Full Analysis

What is Themis Medicare FFO?

FFO (Funds from operations) only applies to REITs.

NSE:THEMISMED
78GF Score
Themis Medicare Ltd NSE:THEMISMED
FFO is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Themis Medicare (NSE:THEMISMED) Overvalued in 2026?

Based on GuruFocus' analysis, Themis Medicare stock appears to be undervalued. The current stock price of ₹118.59 is trading 20.5% below its estimated GF Value™ of ₹149.24. GuruFocus considers Themis Medicare to be Modestly Undervalued.

Key valuation signals for NSE:THEMISMED:

  • FFO:
  • GF Value™: ₹149.24 vs. price of ₹118.59 (20.5% below fair value)
  • GF Score™: 78/100 with 7 warning signs

No single metric tells the full story. See the NSE:THEMISMED stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Themis Medicare Business Description

Other Exchanges 530199:India
Address Swami Vivekanand Road, 11/12, Udyog Nagar Industrial Estate, Goregaon (West), Mumbai, MH, IND, 400 104
Themis Medicare Ltd is an Indian based company engaged in the manufacturing and marketing of pharmaceutical products. The Company operates only in one business segment which is Pharmaceuticals. Geographically, it derives a majority of revenue from India and also has a presence in the international market. Its product categories include Anti Malarial, CCD products, Nutritional Gummies, and Candy and Other Products such as OD-LM, Dexem, Medzol and Tazowin.
78GF Score

Get the complete analysis for NSE:THEMISMED

FFO is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹118.59
Price
₹149.24
GF Value